These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19713932)

  • 1. Editing independent effects of ADARs on the miRNA/siRNA pathways.
    Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
    EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic and stimulative roles of ADAR1 in RNA silencing.
    Nishikura K; Sakurai M; Ariyoshi K; Ota H
    RNA Biol; 2013 Aug; 10(8):1240-7. PubMed ID: 23949595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells.
    Yang W; Wang Q; Howell KL; Lee JT; Cho DS; Murray JM; Nishikura K
    J Biol Chem; 2005 Feb; 280(5):3946-53. PubMed ID: 15556947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.
    Chen T; Xiang JF; Zhu S; Chen S; Yin QF; Zhang XO; Zhang J; Feng H; Dong R; Li XJ; Yang L; Chen LL
    Cell Res; 2015 Apr; 25(4):459-76. PubMed ID: 25708366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
    Xiang Y; Katrekar D; Mali P
    Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.